Lupin Launches Generic Hypertension Drug In U.S

NEW DELHI: Drugmaker Lupin has launched its Amlodipine and Valsartan tablets, used for treatment of hypertension, in the U.S.market after getting approval from the American health regulator.

The U.S. arm of the company, Lupin Pharmaceuticals Inc., has launched Amlodipine and Valsartan tablets in various strengths in the U.S. market after getting final approval from the United States Food and Drug Administration (USFDA), Lupin said in a statement. Lupin’s Amlodipine and Valsartan tablets are indicated for the treatment of hypertension and to lower blood pressure and is the generic version of Novarts Pharmaceuticals Corp.’s Exforge tablets. As per IMS MAT sales data, Exforge tablets had U.S.sales of $414.9 million. With this approval, the Mumbai-based firm has received six abbreviated new drug approvals in the last three months. Lupin shares were trading at 2,033 a piece on the BSE, up 1.29pct from its previous close.

READ MORE: 10 Road Trips To Crusie The Road With Your Buddies

Top 10 Treks That Will Entice Your Curiosity